V. V. N. K. V. Prasada Raju
Direktor/Vorstandsmitglied bei SUVEN PHARMACEUTICALS LIMITED
Profil
V.
V.
N.
K.
V.
Prasada Raju is currently the Chief Executive Officer, MD & Director at Cohance Lifesciences Ltd.
and the Executive Director & Managing Director at Suven Pharmaceuticals Ltd.
He previously held positions as Director at Granules OmniChem Pvt Ltd., Director at Granules Pharmaceuticals, Inc., Director at USpharma Ltd., and President-Research & Development at Granules India Ltd.
Aktive Positionen von V. V. N. K. V. Prasada Raju
| Unternehmen | Position | Beginn |
|---|---|---|
| SUVEN PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | 29.09.2023 |
Cohance Lifesciences Ltd.
 Cohance Lifesciences Ltd. Pharmaceuticals: MajorHealth Technology Cohance Lifesciences Ltd. manufactures and wholesales pharmaceutical products. Its products include API intermediates, formulations, pre-formulation intermediates, and vigil mechanism. The company is headquartered in Hyderabad, India. | Vorstandsvorsitzender | 10.03.2021 |
Ehemalige bekannte Positionen von V. V. N. K. V. Prasada Raju
| Unternehmen | Position | Ende |
|---|---|---|
| GRANULES INDIA LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
USpharma Ltd.
 USpharma Ltd. Pharmaceuticals: MajorHealth Technology USpharma Ltd. Co. manufactures pharmaceutical products. The private company is based in Miami Lakes, FL. | Direktor/Vorstandsmitglied | - |
Granules OmniChem Pvt Ltd.
 Granules OmniChem Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Ajinomoto Co., Inc., Granules OmniChem Pvt Ltd. is a pharmaceutical ingredient manufacturer. The company is based in Visakhapatnam, India. The company was founded in 2011. Granules OmniChem was acquired by Ajinomoto Bio-Pharma Services from Granules India Ltd. on May 29, 2020 for $15.31 million. | Direktor/Vorstandsmitglied | - |
Granules Pharmaceuticals, Inc.
 Granules Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Granules Pharmaceuticals, Inc. develops and manufactures pharmaceutical formulations. The firm manufactures tablets, pharmaceutical formulation intermediates and active pharmaceutical ingredients. The company is headquartered in Chantilly, VA. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GRANULES INDIA LIMITED | Health Technology |
| SUVEN PHARMACEUTICALS LIMITED | Producer Manufacturing |
| Private Unternehmen | 4 |
|---|---|
Granules Pharmaceuticals, Inc.
Granules Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Granules Pharmaceuticals, Inc. develops and manufactures pharmaceutical formulations. The firm manufactures tablets, pharmaceutical formulation intermediates and active pharmaceutical ingredients. The company is headquartered in Chantilly, VA. | Health Technology |
Cohance Lifesciences Ltd.
Cohance Lifesciences Ltd. Pharmaceuticals: MajorHealth Technology Cohance Lifesciences Ltd. manufactures and wholesales pharmaceutical products. Its products include API intermediates, formulations, pre-formulation intermediates, and vigil mechanism. The company is headquartered in Hyderabad, India. | Health Technology |
Granules OmniChem Pvt Ltd.
Granules OmniChem Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Ajinomoto Co., Inc., Granules OmniChem Pvt Ltd. is a pharmaceutical ingredient manufacturer. The company is based in Visakhapatnam, India. The company was founded in 2011. Granules OmniChem was acquired by Ajinomoto Bio-Pharma Services from Granules India Ltd. on May 29, 2020 for $15.31 million. | Health Technology |
USpharma Ltd.
USpharma Ltd. Pharmaceuticals: MajorHealth Technology USpharma Ltd. Co. manufactures pharmaceutical products. The private company is based in Miami Lakes, FL. | Health Technology |
